Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53

Mack, David H., Vartikar, Jai, Pipas, James M., Laimins, Laimonis A.·1993·Nature
DOI 10.1038/363281a0

Cited by (322)

Items 101–200 of 322

  1. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?
    Charis Eng, Victoria A. Murday, S. Seal, Shehla N. Mohammed, Shirley Victoria Hodgson, M.A. Chaudary, I S Fentiman, B. A. J. Ponder, Rosalind A. Eeles · 1994 · Journal of Medical Genetics
  2. Two Distinct Signaling Pathways Activate the Latent DNA Binding Function of p53 in a Casein Kinase II-independent Manner
    Ted R. Hupp, David Philip Lane · 1995 · Journal of Biological Chemistry
  3. The 1995 Walter Hubert Lecture - molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene
    Curtis C. Harris · 1996 · British Journal of Cancer
  4. Role of p53 in Apoptosis
    Christine E. Canman, Michael B. Kastan · 1997 · Advances in pharmacology
  5. Life and death by P53
    Richard M. Elledge, Wen‐Hwa Lee · 1995 · BioEssays
  6. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor
    Katsuyuki Asaoka, Mitsuhiro Tada, Yutaka Sawamura, Jun Ikeda, Hiroshi Abe · 2000 · Journal of neurosurgery
  7. p53-Mediated Regulation of Proliferating Cell Nuclear Antigen Expression in Cells Exposed to Ionizing Radiation
    Jin Xu, Gilbert F. Morris · 1999 · Molecular and Cellular Biology
  8. Gas1-Induced Growth Suppression Requires a Transactivation-Independent p53 Function
    Giannino Del Sal, Elisabetta M. Ruaro, René Utrera, Charles N. Cole, Arnold J. Levine, Claudio Schneider · 1995 · Molecular and Cellular Biology
  9. No room at the p53 inn
    Jennifer A. Pietenpol, Bert Vogelstein · 1993 · Nature
  10. Wild Type and Mutant p53 Differentially Regulate the Gene Expression of Human Collagenase-3 (hMMP-13)
    Yubo Sun, Jamie M. Cheung, Johanne Martel‐Pelletier, Jean Pierre Pelletier, Leonor Wenger, Roy Davis Altman, David S. Howell, Herman S. Cheung · 2000 · Journal of Biological Chemistry
  11. mdm2: a bridge over the two tumour suppressors, p53 and Rb
    Damian Yap, Jung-Kuang Hsieh, Florence Chan, Xin Lü · 1999 · Oncogene
  12. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor
    Mun-Su Jung, Jeanho Yun, Hee‐Don Chae, Jeong‐Min Kim, Sunchang Kim, Tae-Saeng Choi, Deug Y. Shin · 2001 · Oncogene
  13. New Problems in RNA Polymerase II Transcription Initiation: Matching the Diversity of Core Promoters with a Variety of Promoter Recognition Factors
    Ferenc Muöller, Máté Ágoston Demény, Làszlò Tora · 2007 · Journal of Biological Chemistry
  14. Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53.
    Laura S. Angelo, Moshe Talpaz, Razelle Kurzrock · 2002 · PubMed
  15. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication
    L Duan, Iwata Ozaki, Joseph W. Oakes, J. Paul Taylor, Kamel Khalili, Roger J. Pomerantz · 1994 · Journal of Virology
  16. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
    Céline Gobert, Andrzej Składanowski, Annette Kragh Larsen · 1999 · Proceedings of the National Academy of Sciences
  17. Apoptosis and the cell cycle
    Rati Fotedar, Ludger Diederich, Arun Fotedar · 1996 · Springer eBooks
  18. Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis
    Michelle A. Ozbun, Janet S. Butel · 1995 · Advances in cancer research
  19. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Kalkunte S. Srivenugopal, J Shou, Srinivas Mullapudi, Frederick F. Lang, Jasti Sambasiva Rao, Francis Ali‐Osman · 2001 · PubMed
  20. Scatter Factor and Angiogenesis
    Eliot M. Rosen, Itzhak D. Goldberg · 1995 · Advances in cancer research
  21. Serum insulin-like growth factor-I and breast cancer
    Paolo G. Toniolo, Peter F. Bruning, Arslan Akhmedkhanov, Johannes M.G. Bonfrèr, Karen L. Koenig, Annekatrin Lukanova, Roy E. Shore, Anne Zeleniuch‐Jacquotte · 2000 · International Journal of Cancer
  22. P53 Gene Mutations in Lymphoid Diseases and Their Possible Relevance to Drug Resistance
    Elizabeth W. Newcomb · 1995 · Leukemia & lymphoma/Leukemia and lymphoma
  23. Versatile functions of p53 protein in multicellular organisms
    Peter M. Chumakov · 2007 · Biochemistry (Moscow)
  24. Combinatorial regulation of transcription I: General aspects of transcriptional control
    Patricia Ernst, Stephen T. Smale · 1995 · Immunity
  25. Gene regulation by temperature-sensitive p53 mutants: identification of p53 response genes.
    Leonard Buckbinder, Randy L. Talbott, Bernd R. Seizinger, Nikolai Kley · 1994 · Proceedings of the National Academy of Sciences
  26. p53--An Acrobat in Tumorigenesis
    Ute Martha Moll, Laura Schramm · 1998 · Critical Reviews in Oral Biology & Medicine
  27. Caspase Induction and BCL2 Inhibition in Human Adipose Tissue
    Francisco José Tinahones, Leticia Coín‐Aragüez, Mora Murri, Wilfredo Oliva‐Olivera, María Dolores Mayas Torres, Nuria Barbarroja, Ricardo Gómez‐Huelgas, Marı́a M. Malagón, Rajaa El Bekay · 2012 · Diabetes Care
  28. p21 Ras as a governor of global gene expression.
    Maha Abdellatif, William Robb MacLellan, Michael D. Schneider · 1994 · Journal of Biological Chemistry
  29. Induction of cell growth regulatory genes by p53.
    S L Madden, Elizabeth A. Galella, D Riley, Arthur H. Bertelsen, Gary A. Beaudry · 1996 · PubMed
  30. p53 Stimulates Transcription from the Human Transforming Growth Factor α Promoter: a Potential Growth-Stimulatory Role for p53
    Shin, Tae Ho, Paterson, Andrew J., Kudlow, Jeffrey E. · 1995 · Molecular and Cellular Biology
  31. Core promoter-specific function of a mutant transcription factor TFIID defective in TATA-box binding.
    Ernest Martinez, Qiang Zhou, Noëlle D. L’Étoile, Thomas Oelgeschläger, Arnold J. Berk, Robert G. Roeder · 1995 · Proceedings of the National Academy of Sciences
  32. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein
    G Farmer · 1996 · Nucleic Acids Research
  33. Transcription Reinitiation Rate: a Special Role for the TATA Box
    Dawn Yean, Jay D. Gralla · 1997 · Molecular and Cellular Biology
  34. Regulation of COX-2 Expression in Human Cancers
    Dan A. Dixon · 2003 · KARGER eBooks
  35. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck
    Karin Nylander, P Nilsson, Christer Mehle, Göran Roos · 1995 · British Journal of Cancer
  36. The Gene Encoding p202, an Interferon-inducible Negative Regulator of the p53 Tumor Suppressor, Is a Target of p53-mediated Transcriptional Repression
    Sanjay D’Souza, Hong Xin, Scott Walter, Divaker Choubey · 2001 · Journal of Biological Chemistry
  37. The Structure, Function, and Regulation of Papillomaviral Genes in Infection and Cervical Cancer
    Lubomír P. Turek · 1994 · Advances in virus research
  38. FinO is an RNA chaperone that facilitates sense–antisense RNA interactions
    David C. Arthur, Alexandru F. Ghetu, Michael J. Gubbins, Ross A. Edwards, Laura S. Frost, J. N. Mark Glover · 2003 · The EMBO Journal
  39. Induction of Apoptosis by Saussurea lappa and Pharbitis nil on AGS Gastric Cancer Cells
    Seong‐Gyu Ko, Seung-Hee Koh, Chan‐Yong Jun, Chang-gyu Nam, Hyunsu Bae, Minkyu Shin · 2004 · Biological and Pharmaceutical Bulletin
  40. CREB/ATF-Dependent Repression of Cyclin A by Human T-Cell Leukemia Virus Type 1 Tax Protein
    Karen V. Kibler, Kuan‐Teh Jeang · 2001 · Journal of Virology
  41. Regulatory squelching
    Michael A. Cahill, Wolfram H. Ernst, Ralf Janknecht, Alfred Nordheim · 1994 · FEBS Letters
  42. Wild Type p53 Stimulates Expression from the Human Multidrug Resistance Promoter in a p53-negative Cell Line
    Merrill E. Goldsmith, Jean M. Gudas, Erasmus Schneider, Kenneth H. Cowan · 1995 · Journal of Biological Chemistry
  43. Human tumor suppressor p53 and DNA viruses
    Sophie Collot-Teixeira, J. Bass, François Denis, Sylvie Ranger‐Rogez · 2004 · Reviews in Medical Virology
  44. The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis
    Elisheva Yonish-Rouach · 1996 · Cellular and Molecular Life Sciences
  45. Krüppel-associated box-mediated repression of RNA polymerase II promoters is influenced by the arrangement of basal promoter elements.
    Gina Pengue, Luigi Lania · 1996 · Proceedings of the National Academy of Sciences
  46. Regulation of angiogenesis by scatter factor
    Eliot M. Rosen, I D Goldberg · 1997 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions
  47. Interaction of Oct-1 with TFIIB
    Harikrishna Nakshatri, Poornima Bhat‐Nakshatri, Richard A. Currie · 1995 · Journal of Biological Chemistry
  48. An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele.
    Takafumi Nakamura, José G. Pichel, Lisa Williams‐Simons, H Westphal · 1995 · Proceedings of the National Academy of Sciences
  49. Transcriptional Cofactor CA150 Regulates RNA Polymerase II Elongation in a TATA-Box-Dependent Manner
    Carlos Suñé, Mariano A. García-Blanco · 1999 · Molecular and Cellular Biology
  50. p53 in life and death.
    Akiko Shimamura, David E. Fisher · 1996 · PubMed
  51. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
    Philip K. Liu, Eliyahu Kraus, Tian Wu, Louise C. Strong, Michael A. Tainsky · 1996 · PubMed
  52. Interactions Between Papillomavirus Proteins and Tumor Suppressor Gene Products
    Karen H. Vousden · 1994 · Advances in cancer research
  53. One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
    Levin Böhlig, Karen Rother · 2011 · BioMed Research International
  54. Regulation of p53-Dependent Apoptosis by E1A and E1B
    Eileen White · 1995 · Current topics in microbiology and immunology
  55. Transcriptional Activity of the Paired-like Homeodomain Proteins CHX10 and VSX1
    Kimberley M. Dorval, Brian P. Bobechko, K. Farid Ahmad, Rod Bremner · 2005 · Journal of Biological Chemistry
  56. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure.
    Jonathan Ham, Gertrud Steger, Moshé Yaniv · 1994 · The EMBO Journal
  57. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
    Maria A. Ferraiuolo, Lorena Verduci, Giovanni Blandino, Sabrina Strano · 2017 · International Journal of Molecular Sciences
  58. Physical Interaction and Functional Antagonism between the RNA Polymerase II Elongation Factor ELL and p53
    Noriaki Shinobu, Tatsuya Maeda, Teijiro Aso, Tohru Ito, Takuma Kondo, Katsuro Koike, Masanori Hatakeyama · 1999 · Journal of Biological Chemistry
  59. ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter
    Chantal Desdouets, Catherine Ory, Graziella Matesic, Thierry Soussi, Christian Bréchot, Joëlle Sobczak‐Thépot · 1996 · FEBS Letters
  60. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene
    Uddhav P. Kelavkar, Kamal F. Badr · 1999 · Proceedings of the National Academy of Sciences
  61. Vitamin D-binding Protein Gene Transcription Is Regulated by the Relative Abundance of Hepatocyte Nuclear Factors 1α and 1β
    Young‐Han Song, Kunal Ray, Stephen A. Liebhaber, Nancy E. Cooke · 1998 · Journal of Biological Chemistry
  62. p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin Gene
    Stefan Kubicka, Florian Kühnel, Lars Zender, K. Lenhard Rudolph, Jörg Plümpe, Michael Peter Manns, Christian Trautwein · 1999 · Journal of Biological Chemistry
  63. Transactivation of Prothymosin α and c-mycPromoters by Human Papillomavirus Type 16 E6 Protein
    Tomoaki Kinoshita, Hiroshi Shirasawa, Yuji Shino, Hideshige Moriya, Laurie Desbarats, Martin Eilers, Bunsiti Simizu · 1997 · Virology
  64. Structural organization of the 5′ flanking region of the human corticotropin releasing hormone gene
    Nicholas C. Vamvakopoulos, George Panagiotis Chrousos · 1993 · DNA sequence
  65. The Regulation of HIV-1 Gene Expression: The Emerging Role of Chromatin
    Guocheng He, Loyda Ylisastigui, David M. Margolis · 2002 · DNA and Cell Biology
  66. HIV Tat represses transcription through Spl-Like elements in the basal promoter
    T. Kevin Howcroft, Lisa A. Palmer, Julie Brown, Barbara L. Rellahan, Fatah Kashanchi, John N Brady, Dinah S. Singer · 1995 · Immunity
  67. The Importance of p53 Gene Alterations in Human Cancer: Is There More Than Circumstantial Evidence?
    Thierry Frébourg, Stephen Henry Friend · 1993 · JNCI Journal of the National Cancer Institute
  68. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines
    Jing Xu, George T Loo · 2001 · Journal of Cellular Biochemistry
  69. p53-dependent Transcriptional Regulation of theAPC Promoter in Colon Cancer Cells Treated with DNA Alkylating Agents
    Aruna Shanker Jaiswal, Satya Narayan · 2001 · Journal of Biological Chemistry
  70. Reversal of In Vitro p53 Squelching by both TFIIB and TFIID
    Xuan Eric Liu, Arnold J. Berk · 1995 · Molecular and Cellular Biology
  71. Negative Regulation of Chk2 Expression by p53 Is Dependent on the CCAAT-binding Transcription Factor NF-Y
    Taido Matsui, Yuko Katsuno, Tomoharu Inoue, Fumitaka Fujita, Takashi Joh, Hiroyuki Niida, Hiroshi Murakami, Makoto Itoh, Makoto Nakanishi · 2004 · Journal of Biological Chemistry
  72. Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts
    Jane F. Cavender, A. R. Conn, Mark J. Epler, Holly A. Lacko, Mary Judith Tevethia · 1995 · Journal of Virology
  73. Genetic Analysis of the Human Papillomavirus Type 31 Differentiation-Dependent Late Promoter
    Jason M. Bodily, Craig Meyers · 2005 · Journal of Virology
  74. Inhibition of Mouse Thymidylate Synthase Promoter Activity by the Wild-Type p53 Tumor Suppressor Protein
    Yuandan Lee, Yan Chen, Long‐Sheng Chang, Lee F. Johnson · 1997 · Experimental Cell Research
  75. ZNF76, a Novel Transcriptional Repressor Targeting TATA-binding Protein, Is Modulated by Sumoylation
    Gang Zheng, Yu‐Chung Yang · 2004 · Journal of Biological Chemistry
  76. Mdm-2 binding and TAFII31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21
    James R Jabbur, A Tabor, Xiaodong Cheng, Hua Wang, Motonari Uesugi, Guillermina Lozano, Wei Zhang · 2002 · Oncogene
  77. Relative Strength of Cation-π vs Salt-Bridge Interactions: The Gtα(340−350) Peptide/Rhodopsin System
    Matthew A. Anderson, Benhur Ogbay, Rieko Arimoto, Wei Sha, Oleg G. Kisselev, David P. Cistola, Garland R. Marshall · 2006 · Journal of the American Chemical Society
  78. Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    William Loging, David Reisman · 1999 · Oncogene
  79. Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
    Young‐Eun Joo, Ik‐Joo Chung, Youngkyu Park, Yang‐Seok Koh, Jae-Hyuk Lee, Chang‐Hwan Park, Wan‐Sik Lee, Hyun‐Soo Kim, Sung-Kyu Choi, Jong‐Sun Rew et al. · 2006 · Journal of Korean Medical Science
  80. Induction of p53-dependent Activation of the Human Proliferating Cell Nuclear Antigen Gene in Chromatin by Ionizing Radiation
    Bin Shan, Jin Xu, Ying Zhuo, Cindy A. Morris, Gilbert F. Morris · 2003 · Journal of Biological Chemistry
  81. X-gene Product Antagonizes the p53-mediated Inhibition of Hepatitis B Virus Replication through Regulation of the Pregenomic/Core Promoter
    Hyun‐Sook Lee, Young‐Ho Lee, Yun-Sil Huh, H R Moon, Yungdae Yun · 1995 · Journal of Biological Chemistry
  82. Thymidine Dinucleotides Inhibit Contact Hypersensitivity and Activate the Gene for Tumor Necrosis Factor α11The authors did not submit a completed declaration of conflict of interest form as requested by the JID’s ‘‘Information for authors’’.
    Ponciano D. Cruz, Irene I. Dougherty, Martin Leverkus, Michelle J. Gleason, Mark S. Eller, Mina Yaar, Barbara A. Gilchrest · 2000 · Journal of Investigative Dermatology
  83. p53-Mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y
    Maria Concetta Faniello, Maddalena Di Sanzo, Barbara Quaresima, Francesco Baudi, Valentina Di Caro, Giovanni Cuda, Giovanni Morrone, Giannino Del Sal, Giovanni Spinelli, Salvatore Venuta et al. · 2008 · The International Journal of Biochemistry & Cell Biology
  84. T-oligo Treatment Decreases Constitutive and UVB-induced COX-2 Levels through p53- and NFκB-dependent Repression of the COX-2 Promoter
    Vaneeta Marwaha, Yahui Chen, Elizabeth Helms, Simin Arad, Hiroyasu Inoue, Evelyn Bord, Raj Kishore, Raffi Der Sarkissian, Barbara A. Gilchrest, David A. Goukassian · 2005 · Journal of Biological Chemistry
  85. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
    Masato Takahashi, Naohiko Seki, Toshinori Ozaki, Masaki Kato, Tomoko Kuno, Takahito Nakagawa, Kenichi Watanabe, Koh Miyazaki, Miki Ohira, Shunji Hayashi et al. · 2002 · PubMed
  86. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome
    Torsten Stein, Diane Crighton, John Michael Boyle, J M Varley, Robert J. White · 2002 · Oncogene
  87. The p53 tumor suppressor gene
    Thierry Soussi · 1995 · Advances in genome biology
  88. p53 Inhibits DNA Replication In Vitro in a DNA-Binding-Dependent Manner
    Scott D. Miller, George Farmer, Carol L. Prives · 1995 · Molecular and Cellular Biology
  89. Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells
    Chee‐Yin Chai, Yu‐Chun Huang, Wei‐Chun Hung, Wan-Yi Kang, W.-T. Chen · 2007 · Mutagenesis
  90. Expression of MXI1, a Myc Antagonist, Is Regulated by Sp1 and AP2
    Linda Q. Benson, Melissa R. Coon, Leslie M. Krueger, Grace C. Han, Amod A. Sarnaik, Daniel S. Wechsler · 1999 · Journal of Biological Chemistry
  91. Lessons from thep53 mutant mouse
    Tyler Jacks · 1996 · Journal of Cancer Research and Clinical Oncology
  92. CMV promoter is repressed by p53 and activated by JNK pathway
    Marianna Rodova, Renuka Jayini, Reddy Singasani, Elizabeth Chipps, Mohammad R Islam · 2013 · Plasmid
  93. The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein
    Shinichiro Takahashi, Jonathan D. Licht · 2002 · Leukemia
  94. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis
    Jian Hong Gu, Lidong Zhang, Stephen G. Swisher, Jinsong Liu, Jack A. Roth, Bingliang Fang · 2003 · Oncogene
  95. Tissue-specific p53 expression in the nervous system
    Y Tendler, Gary Weisinger, Raymond Coleman, Eric Diamond, Sophie Lischinsky, Hedviga Kerner, Varda Rotter, Oren Zinder · 1999 · Molecular Brain Research
  96. Tumor Suppressor Genes and Human Cancer
    Melissa A. Brown · 1997 · Advances in genetics
  97. Hot-Spot p53 Mutants Interact Specifically with Two Cellular Proteins during Progression of the Cell Cycle
    Y Chen, Phang‐Lang Chen, Wen‐Hwa Lee · 1994 · Molecular and Cellular Biology
  98. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors
    Majid Kheirollahi, Masoud Mehrazin, Naser Kamalian, Parvin Mehdipour · 2010 · Medical Oncology
  99. Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non–Small-Cell Lung Cancer
    Ang Yuan, Chong‐Jen Yu, Kwen‐Tay Luh, Sow-Hsong Kuo, Yung-Chie Lee, Pan‐Chyr Yang · 2002 · Journal of Clinical Oncology
  100. Li-Fraumeni Syndrome and the Role of the p53 Tumor Suppressor Gene in Cancer Susceptibility
    MAKOTO AKASHI, H. Phillip Koeffler · 1998 · Clinical Obstetrics & Gynecology